What Abortion Pill Ruling Means for FDA Future Authority |Pacific Updates

[ad_1] When a Texas district judge ruled on Apr. 7 that mifepristone, a drug for inducing abortion, should have its approval suspended—decades after it was granted—the decision didn’t just threaten abortion access. It raised deeper questions about the U.S. Food and Drug Administration (FDA)’s authority and the separation of its regulatory powers from judicial oversight….

Read More